Skip to main content
Clinical Trials/IRCT20210718051920N2
IRCT20210718051920N2RecruitingPhase 3

Evaluation of the efficacy of nasal spray formulation containing tea tree oil in the treatment of seasonal allergic rhinitis: a randomized double-blind placebo-controlled clinical trial

Kerman University of Medical Sciences0 sites70 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Recruiting
Enrollment
70

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to 65 years (—)
Sex
All

Inclusion Criteria

  • Seasonal allergic rhinitis confirmed by skin prick test

Exclusion Criteria

  • Structural disorders of the nose such as nasal polyps, nasal deviation and other structural disorders
  • Chronic obstructive pulmonary disease (COPD)
  • Rhinosinusitis
  • Chronic diseases such as kidney failure, liver failure, hypertension, diabetes, ischemic heart disease, Malignancy, and systemic inflammatory diseases
  • Respiratory infections during the previous 8 weeks
  • Use of oral corticosteroids during the previous week
  • Patients who are receiving immunotherapy or have a history of immunotherapy

Investigators

Similar Trials